200HO11934 NEXUS

Print/PDF
Registration Name PEAK NEXUS-ET
Registration Number HOCAN000013483346
Primary NAAB Code 200HO11934
Secondary Code(s) 722HO11934, 723HO11934
Status Progeny Test
Controller Name Semex Alliance (200)
Date of Birth 8/7/2019
aAa -
DMS 135,561
GFI 12.8%
Genetic Codes * TL TY TV TP TD TR TC TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire BOMAZ ALTACABOT-ET
MGS MELARRY JOSUPER FRAZZLED-ET
Beta Casein A2A2
Kappa Casein AB
Beta Lactoglobulin -
INDEXES
NM$ 354, 87% R CM$ 382
NM Percentile 36% FM$ 297
GTPI 2812 GM$ 329
PRODUCTION TRAITS
1488 Dtrs 407 herds 5 % US 95% R
Milk -66 Fat, % -3 , 0.00%
SCS 2.55, 93% R Protein, % 11 , +0.05%
Feed Saved 6 , 57% R Milking Speed 6.93 , 83% R
Health & Fertility
Productive Life 4.9      90% R Mastitis 2.6      84% R
Heifer Livability 1.2       63% R Metritis 0.9      75% R
Livability 4.8      78% R D. Abom 0.6      81% R
DPR 2.6      90% R Ketosis 1.2      74% R
FSC 7.9      89% R R. Placenta -0.4      76% R
HCR -       86% R Milk Fever 0.3      68% R
CCR 2.5      89% R
SCR -        -
DIA 0.7      48% R
RSP -       58% R
Calving Traits
Sire CE 1.2      85% R 2269 Obs
Daughter CE 1.2      79% R 26 Obs, 1142 Dtrs
Sire SB 3.0      75% R 2348 Obs
Daughter SB 2.9      81% R 26 Obs, Dtrs
Gestation Length -0.9      91% R 8 Obs, 49 Dtrs
Early First Calving 2.0      83% R 12 Obs, 67 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
458 Dtrs 178 herds 88% R
PTA Type -0.29 UDC 0.38
HCC 1.42 BWC 0.80
FLC 0.58
Linear Traits
Stature -1.04
Short
Strength 0.15
Weak
Body Depth -0.91
Shallow
Dairy Form -2.18
Closed
Rump Angle -0.03
Flat
Thurl Width -0.13
Flat
Rear Legs-Side View -0.13
Narrow
Rear Legs-Rear View 0.28
Straight
Foot Angle 0.39
Steep
Feet & Legs Score 0.32
High
F.U. Attachment -0.16
Straight
Rear Udder Height -0.38
Low
Rear Udder Width -1.03
Narrow
Udder Cleft 0.12
Strong
Udder Depth 0.28
Straight
Front Teat Placement -0.94
Wide
Rear Teat Placement -0.91
Wide
Teat Length -0.09
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO